A mouse model of galactose-induced cataracts.

Galactokinase (GK; EC 2.7.1.6) is the first enzyme in the metabolism of galactose. In humans, GK deficiency results in congenital cataracts due to an accumulation of galactitol within the lens. In an attempt to make a galactosemic animal model, we cloned the mouse GK gene (Glk1) and disrupted it by gene targeting. As expected, galactose was very poorly metabolized in GK-deficient mice. In addition, both galactose and galactitol accumulated in tissues of GK-deficient mice. Surprisingly, the GK-deficient animals did not form cataracts even when fed a high galactose diet. However, the introduction of a human aldose reductase transgene into a GK-deficient background resulted in cataract formation within the first postnatal day. This mouse represents the first mouse model for congenital galactosemic cataract.

[1]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[2]  Sookja K. Chung,et al.  Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Leslie,et al.  Galactose Metabolism by the Mouse with Galactose-1-Phosphate Uridyltransferase Deficiency , 2000, Pediatric Research.

[4]  T. Tanimoto,et al.  Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse. , 1995, European journal of biochemistry.

[5]  D. Stambolian,et al.  Novel mutations in 13 probands with galactokinase deficiency , 2000, Human mutation.

[6]  A. Pérez-Lezaun,et al.  A founder mutation in the GK1 gene is responsible for galactokinase deficiency in Roma (Gypsies). , 1999, American Journal of Human Genetics.

[7]  M. Asada,et al.  Molecular characterization of galactokinase deficiency in Japanese patients , 1999, Journal of Human Genetics.

[8]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[9]  Y. Wen,et al.  Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat. , 1993, Current eye research.

[10]  H. Mitchell,,et al.  Cataract in rats fed on high lactose rations. , 1935 .

[11]  R. Gitzelmann,et al.  Galactose Metabolism in a Patient with Hereditary Galactokinase Deficiency , 1974, European journal of clinical investigation.

[12]  A. Drack,et al.  Infantile cataracts. , 1996, Survey of ophthalmology.

[13]  R. Gitzelmann,et al.  Galactitol excretion in the urine of a galactokinase-deficient man☆ , 1966 .

[14]  N. Leslie,et al.  A mouse model of galactose-1-phosphate uridyl transferase deficiency. , 1996, Biochemical and molecular medicine.

[15]  D. Bergsma,et al.  Cloning of the galactokinase cDNA and identification of mutations in two families with cataracts , 1995, Nature Genetics.

[16]  R. Gitzelmann.  Disorders of Galactose Metabolism , 1990 .

[17]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[18]  R. Gitzelmann,et al.  Hypergalactosemia and galactosuria due to galactokinase deficiency in a newborn. , 1968, Pediatrics.

[19]  D. Stambolian,et al.  Cataracts in patients heterozygous for galactokinase deficiency. , 1986, Investigative ophthalmology & visual science.

[20]  V. Schwarz.  Disorders of galactose metabolism , 1969 .

[21]  D. Stambolian,et al.  Galactose and cataract. , 1988, Survey of ophthalmology.

[22]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.

[23]  N. Copeland,et al.  Mouse galactokinase: isolation, characterization, and location on chromosome 11. , 1995, Genome research.